| Thromboembolism |
1 |
1 |
| COVID-19 |
0 |
0.92 |
| Cancer |
0 |
0.98 |
| Head and Neck Cancer |
0 |
0.71 |
| Lung Cancer |
0 |
0.65 |
| Pancreatic Cancer |
0 |
0.63 |
| Gastrointestinal Cancer |
0 |
0.6 |
| Lung Metastases |
0 |
0.5 |
| Anticoagulation Therapy |
0 |
0.39 |
| Deep Venous Thrombosis |
0 |
0.36 |
| Prophylaxis |
0 |
0.36 |
| Pulmonary Embolism |
0 |
0.21 |
| Clinical Guidelines |
0 |
0.16 |
| Thrombosis |
0 |
0.16 |
| Unfractionated Heparin |
0 |
0.13 |
| Vitamin |
0 |
0.13 |
| Brain Tumor |
0 |
0.1 |
| Child |
0 |
0.08 |
| Postoperative |
0 |
0.08 |
| Renal Failure |
0 |
0.06 |
| Brain |
0 |
0.05 |
| Hemorrhage |
0 |
0.05 |
| Inferior Vena Cava (IVC) Filter |
0 |
0.05 |
| Mobility |
0 |
0.05 |
| Neurosurgery |
0 |
0.05 |
| Surgery |
0 |
0.05 |
| Tumor |
0 |
0.05 |
| Acute Leukemia |
0 |
0.04 |
| Acute Lymphoblastic Leukemia |
0 |
0.04 |
| Low-Molecular-Weight Heparin |
0 |
0.04 |
| Abdomen |
0 |
0.03 |
| Aspirin |
0 |
0.03 |
| Chemotherapy |
0 |
0.03 |
| Clinical Research |
0 |
0.03 |
| Drug Interaction |
0 |
0.03 |
| Embolism |
0 |
0.03 |
| Healthcare and Medical Technology |
0 |
0.03 |
| Leukemia |
0 |
0.03 |
| Lung |
0 |
0.03 |
| Multiple Myeloma |
0 |
0.03 |
| Steroids |
0 |
0.03 |
| Vein |
0 |
0.03 |
| Venous Thromboembolism (VTE) |
0 |
0.99 |